Search Results for: pfizer

With a market-smashing yield, solid dividend growth, and the potential that shares are 16% undervalued, income-oriented dividend growth investors ought to take a close look at this stock after its stunning fall.

With a massive yield of 4.5%, solid dividend growth, and the potential that shares are 22% undervalued, this looks like one of the better long-term opportunities in the market for dividend growth investors.

This is a high-quality company with durable competitive advantages. With an exciting upcoming spin-off, a yield more than twice as high as the S&P 500, a modest payout ratio, strong dividend growth, and the potential that shares are 6% undervalued, this looks like a relatively attractive stock in an otherwise elevated market.